Maggie_Bai_Yun_web_large

Maggie Bai

Senior Associate
Hong Kong
About

Maggie’s practice focuses on corporate finance transactions. She has experience advising sponsors and issuers on initial public offerings on the Stock Exchange of Hong Kong Limited, legal compliance matters of PRC-based Hong Kong-listed companies, financing, M&A, and fund formation matters.

Areas of FocusCorporateEquity Capital MarketsMergers and AcquisitionsDebt Capital MarketsFinancial Services
Professional QualificationsNew York

EXPERIENCE

  • Yunnan Jinxun Resources Co., Ltd. (stock code: 3636), in connection with its HKD1.1bn initial public offering of H shares on the Main Board of The Stock Exchange of Hong Kong Limited (HKEx). Yunnan Jinxun Resources Co., Ltd. is a leading manufacturer of high-quality copper cathode with a strong presence in DR Congo and Zambia.*
  • Softcare Limited (stock code: 2698), in connection with its US$306.6 million initial public offering on the Main Board of the HKEx and its US$30 million financing from International Finance Corporation as pre-IPO investor. Softcare Limited develops, manufactures, and sells baby and feminine hygiene products and focuses on fast-growing emerging markets including Africa, Latin America and Central Asia.
  • QuantumPharm Inc. (stock code: 2228) (XtalPi), in connection with its USD126.7m initial public offering on the Main Board of the HKEx. It is the first Specialist Technology Company listing under Chapter 18C of the Listing Rules that came into effect in March 2023. XtalPi is also the first artificial intelligence–powered drug and new material discovery company listed in Hong Kong.*
  • LC Logistics, Inc. (stock code: 2490), in connection with its initial public offering on the Main Board of the HKEx. LC Logistics, Inc. is a leading private cross-border seaborne logistics service provider in China.*
  • Concord Healthcare Group Co., Ltd. (stock code: 2453), representing the joint sponsors and underwriters in connection with its USD72.2m initial public offering of H shares on the Main Board of the HKEx. Concord Healthcare Group Co., Ltd. is an oncology healthcare service provider in China.*
  • TechStar Acquisition Corporation (stock code: 7855), representing joint sponsors and underwriters in connection with its HKD1bn initial public offering on the Main Board of the HKEx. TechStar Acquisition Corporation was a SPAC targeting at new economy sectors.*

    *Denotes experience at a previous firm
Languages
  • Chinese (Mandarin)
  • Chinese (Cantonese)
  • English
Education

  • Northwestern School of Law, LL.M.(Honors)

  • The Chinese University of Hong Kong, LL.M

  • Beijing Forestry University, LL.B

My latest insights

News
Abstract ceiling image

DLA Piper advises on Nsing Tech’s Hong Kong IPO and H share listing

23 March 2026

Connect

Phone

+852 2103 0765
(Work, Honk Kong)
+852 9222 0907
(Mobile, Hong Kong)
CallvCardLinkedInPrint